无症状重度主动脉瓣狭窄的自然病史及早期干预与结局的关系:系统综述与荟萃分析
该系统综述与荟萃分析纳入29项观察性研究共4075例无症状重度主动脉瓣狭窄患者,汇总自然病史事件发生率并评估早期干预与长期生存的关联。结果显示保守治疗期间全因死亡率为4.8/100患者年,早期干预与长期死亡率显著降低相关(HR 0.38,95%CI 0.25-0.58)。
要点
- 无症状重度AS保守治疗期间全因死亡率4.8/100患者年,心脏死亡3.0/100患者年。
- 早期干预与长期全因死亡率显著降低相关(HR 0.38,95%CI 0.25-0.58)。
- 多数患者会出现主动脉瓣干预指征或症状,决策需关注心脏死亡等终点。
核心结论
- 观察性研究数据提示许多无症状重度AS患者会出现主动脉瓣干预指征,其死亡多为心脏性而非仅猝死。
- 早期干预与长期生存改善相关,决策时应考虑猝死以外的终点。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Embase和Cochrane数据库自建库至2020年2月1日。
- 采用随机效应模型汇总估计值。
主要发现
- 保守治疗期间每100患者年全因死亡4.8(95%CI 3.6-6.4),心脏死亡3.0(95%CI 2.2-4.1)。
- 心力衰竭死亡2.0(95%CI 1.3-3.1)/100患者年,猝死1.1(95%CI 0.6-2.1)/100患者年。
- 主动脉瓣干预指征18.1(95%CI 12.8-25.4)/100患者年,症状出现18.5(95%CI 13.4-25.5)/100患者年,主动脉瓣干预19.2(95%CI 15.5-23.8)/100患者年。
- 早期干预与长期全因死亡风险降低相关(HR 0.38,95%CI 0.25-0.58)。
- 与更差预后相关的因素包括AS严重程度、低流速AS、左心室损伤和动脉粥样硬化危险因素。
临床怎么用
- 对无症状重度AS患者应综合评估症状、干预指征及心脏性死亡风险,而非仅关注猝死。
- 早期干预可能改善长期生存,但需结合AS严重程度、血流状态及左心室功能等预后因素个体化决策。
局限性
- 纳入研究以观察性研究为主,早期干预与保守策略的比较可能存在选择偏倚和混杂。
- 原文未报告各研究的异质性定量指标及发表偏倚评估结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Whether intervention should be performed in patients with asymptomatic severe aortic stenosis (AS) remains debated. OBJECTIVE: To meta-analyze the natural history of asymptomatic severe AS and examine the association of early intervention with survival. DATA SOURCES: PubMed, Embase, and Cochrane databases were searched from inception to February 1, 2020. STUDY SELECTION: Observational studies of adult patients with asymptomatic severe AS. DATA EXTRACTION AND SYNTHESIS: Two investigators independently extracted study and patient characteristics, follow-up time, events, and prognostic indicators of events. Random-effects models were used to derive pooled estimates. MAIN OUTCOMES AND MEASURES: The meta-analysis on natural history was performed on the primary end point of all-cause death occurring during a conservative treatment period, with secondary end points consisting of cardiac death, death due to heart failure, sudden death, development of symptoms, development of an indication for aortic valve intervention, and aortic valve intervention. The primary end point for the meta-analysis of early intervention vs a conservative strategy was all-cause death during long-term follow-up. Finally, meta-analysis was performed on the association of prognostic indicators with the composite of death or aortic valve intervention found in multivariable models. RESULTS: A total of 29 studies with 4075 patients with 11 901 years of follow-up were included. Pooled rates per 100 patients per year were 4.8 (95% CI, 3.6-6.4) for all-cause death, 3.0 (95% CI, 2.2-4.1) for cardiac death, 2.0 (95% CI, 1.3-3.1) for death due to heart failure, 1.1 (95% CI, 0.6-2.1) for sudden death, 18.1 (95% CI, 12.8-25.4) for an indication for aortic valve intervention, 18.5 (95% CI, 13.4-25.5) for development of symptoms, and 19.2 (95% CI, 15.5-23.8) for aortic valve intervention. Early intervention was associated with a significant reduction in long-term mortality (hazard ratio, 0.38; 95% CI, 0.25-0.58). Factors associated with worse prognosis were severity of AS, low-flow AS, left ventricular damage, and atherosclerotic risk factors. CONCLUSIONS AND RELEVANCE: Data from observational studies and a recent randomized clinical trial suggest that many patients with asymptomatic severe AS develop an indication for aortic valve intervention, and their deaths are mostly cardiac but not only sudden. Other end points besides sudden death should be considered during the decision to perform early intervention that are associated with improved survival.
引用
- Gahl B, Çelik M, Head SJ, et al. Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes: A Systematic Review and Meta-analysis. JAMA Cardiol. 2020. PMID: 32639521. doi:10.1001/jamacardio.2020.2497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。